BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16969018)

  • 1. [Superselective intra-arterial infusion therapy with docetaxel, cisplatin and 5-fluorouracil for head and neck cancer--for tongue cancer patients in comparison patients with other therapies].
    Furusaka T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1241-6. PubMed ID: 16969018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer.
    Furusaka T; Asakawa T; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2012 Oct; 132(10):1108-14. PubMed ID: 22998559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
    Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for T2-4N0 tongue cancer: control of occult neck metastasis.
    Minamiyama S; Mitsudo K; Hayashi Y; Iida M; Iwai T; Nakashima H; Oguri S; Ozawa T; Koizumi T; Hirota M; Kioi M; Tohnai I
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jul; 124(1):16-23. PubMed ID: 28434836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-arterial chemotherapy for head and neck cancer].
    Tohnai I
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2024-9. PubMed ID: 16352923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.
    Mitsudo K; Koizumi T; Iida M; Iwai T; Oguri S; Yamamoto N; Itoh Y; Kioi M; Hirota M; Tohnai I
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e639-45. PubMed ID: 22543212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.
    Mitsudo K; Koizumi T; Iida M; Iwai T; Nakashima H; Oguri S; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
    Radiother Oncol; 2014 May; 111(2):306-10. PubMed ID: 24746571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced hypopharyngeal carcinoma successfully treated with superselective intra-arterial infusion of docetaxel].
    Akisada T; Harada T; Takemoto T; Fukuda K; Morita N; Aihara T; Kajihara Y; Imai S; Gyoten M; Imajo Y; Hiratsuka J
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):323-8. PubMed ID: 11865643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers.
    Imai S; Kajihara Y; Munemori O; Kamei T; Mori T; Handa T; Akisada K; Orita Y
    Eur J Radiol; 1995 Dec; 21(2):94-9. PubMed ID: 8850500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.
    Hayashi Y; Nakamura T; Mitsudo K; Yamaguchi H; Ono T; Azami Y; Takayama K; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Fuwa N; Tohnai I
    Head Neck; 2016 Aug; 38(8):1145-51. PubMed ID: 27018982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer.
    Kobayashi W; Teh BG; Sakaki H; Sato H; Kimura H; Kakehata S; Nagahata M
    Oral Oncol; 2010 Dec; 46(12):860-3. PubMed ID: 21050802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer].
    Yokoyama J
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):169-75. PubMed ID: 11865620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness and indication of superselective intra-arterial chemotherapy via the radial artery for advanced head and neck cancer--aN indication for inaccessible to treatment with seldingers method].
    Yokoyama J; Ito S; Ohba S; Fujimaki M; Ikeda K; Hanaguri M
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Jun; 115(6):625-31. PubMed ID: 22844823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.